Identifying a suitable human hepatic in vitro model to study aryl hydrocarbon receptor-mediated CYP1A1 and CYP1A2

Ann-Kathrin Lenich1, Lisa-Marie Reindl1, Stephanie Ruez1

  • 1Department of Global Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.

Related Concept Videos